Through “polygenic risk scoring,” researchers can identify people at high risk for disease, even if they don’t present other warning signs; method shows potential for use in the clinic
Following up on findings from genome-wide association studies, researchers identify two mechanisms by which disruptions in the gene SLC16A11 may play a role in type 2 diabetes